May 2011

TrimGen announces the release of Shifted Termination Assay (STA) Core Reagents. The STA Core Reagents give labs the ability to use proprietary STA technology in testing a variety of target genes.

Dr. Howard Doong presents on "The NGS Revolution and its Applications for Mutation Detection and Post-discovery SNP Validation" at the Genomics Users Meeting hosted by the National Taiwan University Medical School.

April 2011

PI3KCA Mutation Analysis Reagents are now available on our Mutector II platform. Like KRAS and BRAF mutations, PI3KCA mutations are commonly associated with sensitivity to chemotherapeutic agents.

TrimGen celebrates the one year anniversary of our distribution agreement with Life Technologies. Life Technologies is the official distributor of our Mutector II KRAS and BRAF products.
          For more information please visit the product pages:
          KRAS Mutation Analysis Reagents
          BRAF Mutation Analysis Reagents

March 2011

Dr. Howard Doong to be a keynote speaker for the Chinese Association for Clinical Biochemistry Symposium at the 26th Joint Annual Conference of Biomedical Sciences in Taipei, Taiwan.

January 2011

TrimGen begins exploring opportunities in Next Generation Sequencing (NGS). Employing proprietary mutation detection technology with NGS instruments will allow us to provide higher throughput, cost effective options to laboratories performing large scale studies.

November 2010

TrimGen receives ISO 9001:2008 Certification. The ISO 9001:2008 registration covers the Quality Management System for the manufacture of sample collection and mutation detection products for nucleic acid-based molecular diagnostics and provision of related test services at TrimGen Corporation.

TrimGen to attend the annual Association of Molecular Pathology meeting in San Jose from the 17th to the 21st. Please come and visit our booths (#1116 and 1118).

October 2010

TrimGen begins interviewing to expand its global sales and marketing force. Interested candidates can email their resume to careers@trimgen.com

September 2010

During the ISO 9001:2008 audits, it has been determined that TrimGen's quality management system is "effectively implemented and meets the requirements of the standard." A recommendation for certification will be submitted to the SAI Global review team.

August 2010

Trimgen completes development of a new assay for detection of EML4-ALK fusion gene variants. These rearranged genes promote tumor cell growth and predict lack of benefit from anti-EGFR therapies. read more...

June 2010

TrimGen restructures its manufacturing facility to comply with ISO 9001 standards.

May 2010

TrimGen's WaxFree products demonstrate excellent performance data. The results are published in the Journal of Analytical Biochemistry, Methods in the Biological Sciences. "Comparison of methods in the recovery of nucleic acids from archival formalin-fixed paraffin-embedded autopsy tissues"